- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
NanoInk'sNano BioDiscovery Division announced today the launch of a new instrument system for nanoscale protein analysis and discovery. Coupling powerful array deposition techniques with the latest generation of fluorescent detection technologies, the NanoArray Assay System is a user friendly, affordable desktop unit that can quickly and cost-effectively integrate into any proteomic lab. The platform is based on NanoInk's patented, tip-based Dip Pen Nanolithography(DPN) technology, which can create highly reproducible protein arrays over millimeter areas with nanometer precision and then fluorescently image these nanoarrays at high resolution.
Components of the NanoArray Assay System include the NanoArrayer 3000, the NanoScan 900 Scanner, and user-friendly software for flexible and precise array patterning and intuitive data acquisition and image analysis. When combined with NanoInk's line of fully automatable proteomic assays, the NanoArray Assay System is a complete solution for the detection, identification, and quantitation of clinically relevant proteins from a wide variety of sample types.
According to Bruce Dudzik, vice president of the Nano BioDiscovery Division, "Other protein analysis platforms require large amounts of sample material and reagents. The NanoArray Assay System generates more data with just 2 ml of sample so that even low-abundance biomarker studies on rare and hard-to-collect samples (like rodent serum, spinal fluid, tissue extracts, tears and dried blood spots) are possible. And with femtofluidic liquid handling, the NanoArray Assay System delivers rapid reaction kinetics and lowers reagent volumes, reducing assay costs."
The NanoArrayer 3000 is capable of depositing thousands of uniform protein features in the area occupied by just one spot on a conventional protein microarray. This miniaturization and precision enables high throughput protein analysis on a single slide. NanoArrayer 3000 arrays are also completely customizable. Multiplexed proteins can be patterned into each sub-array, and modified assay slides can be produced in 18, 48, and 96 sub-array formats.
By incorporating two extremely sensitive photomultipliers, the confocal NanoArray 900 Scanner detects fluorescence uniformly across the entire arrayed surface and delivers exceptional sensitivity and signal-to-noise ratios. Miniaturized and multiplexed NanoArray Assay System assays achieve femtograms/ml sensitivity with 2 l of sample, comparable to or better than the sensitivities of ELISA and bead-based assays that consume 50 l of sample.
Please visit www.nanoink.net/nanobio or call (847)679-3432 for more information on the NanoArray Assay System and other Nano BioDiscovery Division assay kits and contract services for nanoscale protein studies.
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life sciences, engineering, pharmaceutical, and education industries. Using Dip Pen Nanolithography(DPN), a patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily create micro-and nanoscale structures from a variety of materials on a range of substrates. This low cost, easy to use and scalable technique brings sophisticated nanofabrication to the laboratory desktop. Headquartered in the Illinois Science + Technology Park, north of Chicago, NanoInk currently has several divisions including the Nano BioDiscovery Division, the NanoFabrication Systems Division, the NanoProfessor Division and the NanoGuardian Division. For more information on products and services offered by NanoInk, Inc., visit www.nanoink.net.
NanoInk, the NanoInk logo, Nano BioDiscovery, Dip Pen Nanolithography, DPN, NanoGuardian, NanoProfessor and the NanoArrayer 3000 are trademarks or registered trademarks of NanoInk, Inc.
For more information, please click here
Dresner Corporate Services
Dresner Corporate Services
Copyright © NanoInkIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015
Engineering the world’s smallest nanocrystal July 2nd, 2015
Newly-Developed Biosensor in Iran Detects Cocaine Addiction June 23rd, 2015
New conductive ink for electronic apparel June 25th, 2015
Leti to Present Solutions to New Applications Using 3D Technologies at SEMICON West LetiDay Event, July 14: Leti Experts also Will Speak at TechXPOT Session on MEMS and STS Session on Lithography Cost-and-Productivity Issues Below 14nm June 22nd, 2015